Uhr JW - Search Results

1

A phase I study of bolus versus continuous infusion of the anti-CD19 immunotoxin, IgG-HD37-dgA, in patients with B-cell lymphoma.

Stone MJ, Sausville EA, Fay JW, Headlee D, Collins RH, Figg WD, Stetler-Stevenson M, Jain V, Jaffe ES, Solomon D, Lush RM, Senderowicz A, Ghetie V, Schindler J, Uhr JW, Vitetta ES. Stone MJ, et al. Among authors: uhr jw. Blood. 1996 Aug 15;88(4):1188-97. Blood. 1996. PMID: 8695836 Free article. Clinical Trial.

2

A phase-I study of an anti-CD25 ricin A-chain immunotoxin (RFT5-SMPT-dgA) in patients with refractory Hodgkin's lymphoma.

Engert A, Diehl V, Schnell R, Radszuhn A, Hatwig MT, Drillich S, Schön G, Bohlen H, Tesch H, Hansmann ML, Barth S, Schindler J, Ghetie V, Uhr J, Vitetta E. Engert A, et al. Blood. 1997 Jan 15;89(2):403-10. Blood. 1997. PMID: 9002941 Free article. Clinical Trial.

3

The antitumor activity of an anti-CD22 immunotoxin in SCID mice with disseminated Daudi lymphoma is enhanced by either an anti-CD19 antibody or an anti-CD19 immunotoxin.

Ghetie MA, Tucker K, Richardson J, Uhr JW, Vitetta ES. Ghetie MA, et al. Among authors: uhr jw. Blood. 1992 Nov 1;80(9):2315-20. Blood. 1992. PMID: 1384801 Free article.

4

Anti-CD19 inhibits the growth of human B-cell tumor lines in vitro and of Daudi cells in SCID mice by inducing cell cycle arrest.

Ghetie MA, Picker LJ, Richardson JA, Tucker K, Uhr JW, Vitetta ES. Ghetie MA, et al. Among authors: uhr jw. Blood. 1994 Mar 1;83(5):1329-36. Blood. 1994. PMID: 7509655 Free article.

5

Eradication of minimal disease in severe combined immunodeficient mice with disseminated Daudi lymphoma using chemotherapy and an immunotoxin cocktail.

Ghetie MA, Tucker K, Richardson J, Uhr JW, Vitetta ES. Ghetie MA, et al. Among authors: uhr jw. Blood. 1994 Aug 1;84(3):702-7. Blood. 1994. PMID: 7519071 Free article.

6

The toxicity of chemically deglycosylated ricin A-chain in mice.

Soler-Rodriguez AM, Uhr JW, Richardson J, Vitetta ES. Soler-Rodriguez AM, et al. Among authors: uhr jw. Int J Immunopharmacol. 1992 Feb;14(2):281-91. doi: 10.1016/0192-0561(92)90041-i. Int J Immunopharmacol. 1992. PMID: 1624227

7

Covalent binding of human alpha 2-macroglobulin to deglycosylated ricin A chain and its immunotoxins.

Ghetie MA, Uhr JW, Vitetta ES. Ghetie MA, et al. Among authors: uhr jw. Cancer Res. 1991 Mar 1;51(5):1482-7. Cancer Res. 1991. PMID: 1705175

8

The GLP large scale preparation of immunotoxins containing deglycosylated ricin A chain and a hindered disulfide bond.

Ghetie V, Thorpe P, Ghetie MA, Knowles P, Uhr JW, Vitetta ES. Ghetie V, et al. Among authors: uhr jw. J Immunol Methods. 1991 Sep 13;142(2):223-30. doi: 10.1016/0022-1759(91)90110-2. J Immunol Methods. 1991. PMID: 1717600

9

Antitumor activity of Fab' and IgG-anti-CD22 immunotoxins in disseminated human B lymphoma grown in mice with severe combined immunodeficiency disease: effect on tumor cells in extranodal sites.

Ghetie MA, Richardson J, Tucker T, Jones D, Uhr JW, Vitetta ES. Ghetie MA, et al. Among authors: uhr jw. Cancer Res. 1991 Nov 1;51(21):5876-80. Cancer Res. 1991. PMID: 1933855

10

Immunoconjugates containing ricin A chain and either human anti-gp41 or CD4 kill H9 cells infected with different isolates of HIV, but do not inhibit normal T or B cell function.

Till MA, Ghetie V, May RD, Auerbach PC, Zolla-Pazner S, Gorny MK, Gregory T, Uhr JW, Vitetta ES. Till MA, et al. Among authors: uhr jw. J Acquir Immune Defic Syndr (1988). 1990;3(6):609-14. J Acquir Immune Defic Syndr (1988). 1990. PMID: 2140127

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

316 results

Search Page

Filters